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ABSTRACT Human and mouse lymphocytes of T- and B-cell
lineages express a protein (Mr, 240,000) that crossreacts with an-
tibodies raised against chicken erythrocyte a-spectrin as judged
by immunofluorescence, immunoprecipitation, and immunoau-
toradiography; by the same criteria, antibodies raised against
chicken erythrocyte -spectrin do not react with any lymphocyte
polypeptide. In all T and B cells analyzed, before surface-directed
ligand challenge with concanavalin A and surface immunoglobu-
lins the polypeptide antigenically related to erythrocyte Of-spectrin
is distributed diffusely at the plasma membrane. Upon challenge,
the redistribution of this polypeptide is concurrent with that ofthe
cell-surface receptors initially in patches and then in a cap. Im-
munoprecipitation of NaDodSO4-solubifized lymphocytes with
erythrocyte a-spectrin antiserum shows that in all cases a poly-
peptide with the same apparent molecular weight as erythrocyte
a-spectrin is precipitated. Variable amounts of another polypep-
tide (Mr, 235,000) are also coimmunoprecipitated. Immunopre-
cipitations and subsequent immunoautoradiography show that the
lymphocyte polypeptide doublet has a composition similar to that
of (brain) fodrin, a polypeptide doublet that previously has been
found mainly in the cells of nervous tissue.
The redistribution ofcell-surface receptors with ligands and im-
munoglobulins initially involves the aggregation of the recep-
tors into patches, presumably by the diffusion ofthe crosslinked
receptors in the plane ofthe membrane, followed by the move-
ment of these patches into a polar cap (1-3). The latter is an
energy-dependent nondiffusional process thought to result
from a transmembrane association of the receptors with cyto-
skeletal elements in the cell cortex (4-9). Despite extensive in-
vestigations, however, the role ofthe cytoskeleton in the patch-
ing and capping of cell-surface receptors in lymphocytes (for a
review, see ref. 9) and the problem ofhow the cytoskeleton in-
teracts with the plasma membrane to a great extent remains
unknown. This interaction in the erythrocyte, on the other
hand, is well understood and has been shown to be mediated
by spectrin, a protein composed of two nonidentical polypep-
tide subunits (a-spectrin, Mr 240,000; /3-spectrin, Mr 220,000)
(for a review, see ref. 10).
Recently, it has been shown that nonerythroid cells also ex-
press polypeptides that appear to be biochemically and anti-
genically related to erythrocyte spectrin (ref. 11-18; see also ref.
19). Some cells (e.g., adult cardiac and skeletal muscle cells)
express equimolar amounts of polypeptides antigenically re-
lated to erythrocyte a- and f3-spectrin (18), whereas other cells
(e.g., in nervous tissue) express a polypeptide doublet [termed
"fodrin" (13)] composed of a 240,000-dalton component that is
antigenically related to erythrocyte a-spectrin and a smaller
(235,000) component that does not crossreact with either eryth-
rocyte a- or B-spectrin antiserum (18).
In view of the dynamic role of the cytoskeleton during the
patching and capping of cell-surface receptors, we have inves-
tigated the composition ofpolypeptides antigenically related to
erythrocyte spectrin in lymphocytes. Our results show that a
polypeptide doublet, similar to fodrin in nervous tissue, is im-
munoprecipitated with erythrocyte a-spectrin antibodies. Upon
challenge with cell-surface-directed ligands, the redistribution
of the polypeptide antigenically related to erythrocyte a-spec-
trin follows that of the cell-surface receptors, suggesting that
in these cells this erythrocyte spectrin-related polypeptide
complex may function to integrate the cytoskeleton with the
transmembrane protein-cell surface receptor complex.
MATERIALS AND METHODS
Cells. The following lymphoid cell lines were cultured in
vitro: human T-cell lineage, 8402 and CEM; human B-cell lin-
eage, Raji and Daudi; human null cell lineage, Nalm 6; human
mastocytoma, P815; mouse T-cell lineage, EL4 and Yac-1; and
mouse B-cell lineage, Sp2 and Nsl hybrids. Short-term cultures
were grown to a density of 5 x 106 cells per ml in RPM1 1640
medium (GIBCO) supplemented with 1% glutamine and 10%
fetal calf serum.
Antibodies. Antibodies raised against electrophoretically pu-
rified chicken erythrocyte a-spectrin (11) and 83-spectrin (18)
have been characterized in detail elsewhere.
Immunofluorescence. Surface-receptor capping and the dis-
tribution of polypeptides antigenically related to erythrocyte
spectrin in lymphocytes were followed in the same cell. Lym-
phocytes were induced to cap in the presence of either rho-
damine-labeled concanavalin A (ConA) (50 ,ug/ml; Polysci-
ences) or goat anti-mouse Ig antiserum (Miles) in the culture
medium at room temperature. Control cells were incubated in
the absence of ligand. At various times after the addition of Con
A or Ig, the cells were pelleted and fixed in phosphate-buffered
saline (Pi/NaCI) containing 2% formaldehyde and 0.5% Triton
X-100 for 5 min at room temperature. The cells were then washed
in the same buffer but without formaldehyde and incubated with
preimmune serum or with erythrocyte a- or ,B-spectrin anti-
serum at a dilution of 1:100 in Pi/NaCl for 30 min at room tem-
perature. The cells were either in suspension or attached to
polylysine-coated coverslips. After extensive washing with
Pi/NaCl, the cells were incubated with fluorescein isothio-
cyante-labeled goat anti-rabbit Ig antisera (1:150 dilution; Miles)
for 30 min at room temperature. The cells were again washed
extensively in Pi/NaCl and examined in a Leitz phase-con-
trast/epifluorescence microscope.
Abbreviations: ConA, concanavalin A; Pi/NaCl, phosphate-buffered sa-
line.
* Present address: Imperial Cancer Research Fund Laboratories, Lon-
don, England.
1626
The publication costs ofthis article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertise-
ment" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 80 (1983) 1627
Immunoprecipitation and Imniunoautoradiography. Im-
munoprecipitation of polypeptides from lymphocytesand brain
tissue was performed according to the method of Lingappa et
aL (20) as- modified by Levine and Willard (13). We used 5-20
x 106 lymphocytes for each immunoprecipitation with 1: 100-
1:500 dilution of the appropriate antiserum. Immunoprecipi-
tated proteins were separated by NaDodSO4/10% polyacryl-
amide gel electrophoresis based on the system of Laemmli (21)
as modified (22). Immunoautoradiography (23) was performed
as described (24).
RESULTS
Immunofluorescence. Fig. 1 shows the patching and capping
of the ConA surface receptors of Nsl hybrid cells in suspension.
-Similar results were also obtained with Raji and EL4 cells and
with surface immunoglobulin capping in Nsl hybrids (not shown).
Phase-contrast microscopy of the-Nsi hybrid cells showed that
the overall cell morphology and, in particular, the plasma mem-
brane were well preserved under the -incubation and fixa-
tion/permeabilization conditions used in this study (Fig. 1 c, f,
and g). At time 0, the ConA receptors were evenly' distributed
over the entire surface of the plasma membrane (Fig. la). In-
direct immunofluorescence microscopy of the same cell after
incubation with erythrocyte a-spectrin antiserum showed that
'all~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i
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FIG. 1. Fluorescence and phase-contrast microscopy of Nsl hybrid
cells at various stages of capping of ConA cell-surface receptors: time
0, a, b, and-c; 15. min, d, e, andf; 30 min,g, A, i,j,k, and 1. Fluorescence
micrographs of the same cell at each time point showthe distribution
of ConA (a, d, g, andj), a-spectrin (b, e, and h), and 3-spectrin (k); 1
shows the control with preimmune serum. The cell-surface receptors
were directly labeled with rhodamine-conjugated ConA and the dis-
tribution of a- and 3-spectrin was visualized by using indirect im-
munofluorescence with fluorescein isothiocynate-labeled goat anti-
rabbit antisera: c, f, and i show the phase-contrast images of the same
cell shown in the fluorescence micrographs at each point. (Bar = 5 tim.)
the crossreacting antigen(s) is also diffusely distributed over the
inner surface of- the plasma membrane (Fig. lb). Cells not per-
meabilized with Triton X-100 showed no fluorescence with a-
spectrin antiserum, demonstrating that the crossreacting anti-
gen(s) is distributed on the cytoplasmic side of the plasma mem-
brane (not shown).
After'15 min of incubation, the ConA fluorescence revealed
the redistribution of surface receptors into several patches (Fig.
1d). The distribution of the crossreacting antigen(s) was coin-
cidental with that of the ConA receptors, with intense fluores-
cence at the site of each patch (Fig. le). After 30 min of in-
cubation, all the patches containing ConA receptors had coalesced
into a single cap (Fig. 1g); the erythrocyte a-spectrin antibody
fluorescence alsowas concentrated exclusively at the polar cap
(Fig. 1 h and j). In parallel 'experiments using erythrocyte /3-
spectrin antiserum, fluorescence staining was not observed at
any stage of the-capping process (Fig., 1k). The preimmune serum
also gave negligible fluorescence (Fig. 11).
Immunoprecipitation and Immunoautoradiography. Fig. 2a
-shows the polypeptides immunoprecipitated from Yac-1 mouse
T cells with preimmune serum and erythrocyte a- and /3-spec-
trin antisera, respectively. A polypeptide with an apparent mo-
lecular weight similar to that of human erythrocyte a-spectrin
(Mr 240,000; Fig. 2b, lane 1) was immunoprecipitated with a-
spectrin antiserum (Fig. 2a, lane 2). A minor protein (black dot)
also was immunoprecipitated with the preimmune serum and
thus represents a nonspecific reactant with erythrocyte a-spec-
trin antiserum (see also Fig. 3). The erythrocyte /B-spectrin anti-
serum did not immunoprecipitate any polypeptide as deter-
mined by Coomassie blue-staining (Fig. 2a, lane 3). In the other
cell lines analyzed, a complex of two polypeptides was specif-
ically immunoprecipitated with erythrocyte a-spectrin anti-
serum and was composed of a major polypeptide (apparent Mr
240,000) and another polypeptide (apparent Mr about 235,000)
(Fig. 2b). The amount of the lower component varied between
different cell lines and between experiments (compare Yac-l
immunoprecipitates in Fig. 2a, lane 2 .and Fig. 2b, lane 8), in-
dicating that the complex'between the Mr 240,000 and 235,000
polypeptides is relatively labile under these immunoprecipi-
tation conditions. Interestingly, the immunoprecipitates of
lymphocytes of T-cell lineage have a relatively higher concen-
tration of this doublet than do those of B-cell lineage, null cells,
and the mastocytoma (Fig. 2b).
By immunoautoradiography of the gel shown in Fig. 2b with
erythrocyte a-spectrin- antiserum, it was found that the upper
polypeptide (Mr 240,000) of the doublet crossreacted with a-
spectrin antiserum but the lower component (Mr 235,000) did
not (Fig. 2c, lanes 4-6); shorter exposures of the immunoau-
toradiogram than those shown here unambiguously demon-
strate that in the remaining cell lines only the upper component
crossreacted with the erythrocyte a-spectrin antiserum (data not
shown). The labeled polypeptides smaller than the crossreact-
ing polypeptide represent degradation products from. this pro-
tein (Fig. 2c) (for comparison see ref. 11). Neither component
of the doublet crossreacted with erythrocyte 3-spectrin anti-
serum- (not shown). Fig. 2d shows the immunoprecipitates of
NaDodSO4-solubilized lymphocytes with erythrocyte /3-spec-
trin antiserum. By Coomassie blue staining, there does not ap-
pear to be any polypeptide specifically immunoprecipitated.
This was also confirmed by immunoautoradiography witheryth-
rocyte ,/3spectrin antiserum of the gel shown in Fig. 2d (see Fig.
2e).
These results show that the composition of polypeptides re-
lated to erythrocyte spectrin in the lymphocyte is different from
that described in adult cardiac and skeletalmuscle cells (18) but
appears to be similar to that found in nervous tissue (13, 15-17).
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FIG. 2. NaDodSO4/10% polyacrylamide gels of immunoprecipitates, and their corresponding immunoautoradiograms, of human and mouse
lymphocytes of T- and B-cell lineage with a- and ,3spectrin antisera. NaDodSO4-solubilized proteins from lymphocytes were incubated with a-
and /-spectrin antisera, respectively, and the immune complex was precipitated with protein A-bearing staphylococci. The resulting immunopre-
cipitates were analyzed on NaDodSO4/10% polyacrylamide gels followed by immunoautoradiography. (a) Coomassie blue-stained gel of immu-
noprecipitates of Yac-1 cells with preimmune (lane 1), a-spectrin (lane 2), and (3-spectrin (lane 3) antisera (13 x 106 cells per immunoprecipitate).
(b and c) Coomassie blue-stained gel (b) of immunoprecipitates of lymphocytes with a-spectrin antiserum and its corresponding immunoautora-
diogram with a-spectrin antiserum (c)-lanes: 1 and 11, human erythrocyte ghosts as markers for a-spectrin (Mr 240,000) and (-spectrin (Mr
220,000); 2, CEM (10 x 106 cells); 3, Nalm 6 (5 x 106 cells); 4, Daudi (10 x 106 cells); 5, Raji (10 x 106 cells); 6, P815 mastocytoma (6 x 106 cells);
7, EL4 (10 x 106 cells); 8, Yac-1 (20 x 106 cells); 9, Sp2 (15 x 106 cells); 10 Nsl hybrids (20 x 106 cells). (d and e) Coomassie blue-stained gel (d)
of immunoprecipitates of lymphocytes with ,-spectrin antiserum and its corresponding immunoautoradiogram with t3-spectrin antiserum (e); the
lane order and numbers of cells used for each immunoprecipitate are exactly as in b and c.
C
To examine this further, we immunoprecipitated NaDodSO4-
solubilized whole 10-day chicken embryo brain and adult mouse
brain with chicken erythrocyte a- and ,3-spectrin antisera.
Erythrocyte a-spectrin antiserum immunoprecipitated a poly-
peptide doublet from both chicken and mouse brain (Fig. 3a,
lanes 2 and 3, respectively), the upper component of which had
an apparent Mr of 240,000, similar to that of chicken and human
erythrocyte a-spectrin (lanes 6 and 5, respectively); the lower
component had an apparent Mr of =235,000 and showed a slight
difference in electrophoretic mobility between chicken and mouse
brain. However, the polypeptide doublet from mouse brain ap-
peared to be similar in electrophoretic mobility to that immu-
noprecipitated from mouse (and human) lymphocytes with
erythrocyte a-spectrin antiserum (compare with Fig. 2b). The
amount of the Mr 235,000 component from mouse brain varied
between preparations, as in the case of the lymphocyte poly-
peptide (see above). The parallel immunoprecipitations with
erythrocyte ,B-spectrin antiserum show that comparatively much
lower concentrations (if any) of serologically crossreactive forms
of erythrocyte ,3-spectrin are present in brain.
The corresponding immunoautoradiogram with erythrocyte
a-spectrin antiserum (Fig. 3b) shows that only the upper com-
ponent of the polypeptide doublet immunoprecipitated with a-
spectrin antiserum from chicken and mouse brain crossreacts
(lanes 2 and 3), as in the case of the lymphocytes (compare with
Fig. 2c). However, this sensitive technique also demonstrated
the presence of a polypeptide antigenically related to eryth-
rocyte a-spectrin in the (-spectrin immunoprecipitates ofchicken
and mouse brain (Fig. 3b, lanes 1 and 4, respectively). This
technique was also applied to immunoprecipitates of lympho-
cytes. Fig. 3c shows a Coomassie blue-stained polyacrylamide
gel of the immunoprecipitates of human and mouse lympho-
cytes of T- and B-cell lineage, respectively, with /-spectrin
antiserum. Fig. 3d shows the corresponding immunoautora-
diogram with erythrocyte a-spectrin antiserum. The polypep-
tide doublet immunoprecipitated with a-spectrin (see Fig. Zb)
was not immunoprecipitated with ,B-spectrin antiserum (see also
ref. 18). The results of use of this sensitive indirect technique
to probe for the presence of /3-spectrin in lymphocytes sub-
stantiates the results obtained with direct approaches-that a
serologically crossreacting form of erythrocyte /3-spectrin is not
present.
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FIG. 3. Coomassie blue-stained NaDodSO4/10% polyacrylamide gels of immunoprecipitates of chicken and mouse brain and lymphocyte poly-
peptides and their corresponding immunoautoradiograms with a- and 0- spectrin antisera. For details of the experimental procedure see the legend
to Fig. 2. (a) Coomassie blue-stained gel of immunoprecipitates of NaDodSO4-solubilized whole 10-day chicken embryo brain (lanes 1 and 2) and
adult mouse brain (lanes 3 and 4) with a-spectrin (lanes 2 and 3) and P-spectrin (lanes 1 and 4) antisera; lane 5, human erythrocyte ghosts; lane
6, purified chicken erythrocyte membranes. (b) Corresponding immunoautoradiogram of the gel in a with a-spectrin antiserum. (c) Coomassie blue-
stained gel of immunoprecipitates of lymphocytes of CEM (lane 2), Raji (lane 3), EL4 (lane 5), and Nsl hybrid (lane 6) cell lines with (-spectrin
antiserum; lanes 1, 4, 7, human erythrocyte ghosts. (d) Corresponding immunoautoradiogram of c with a-spectrin antiserum.
DISCUSSION
The results of this study demonstrate the presence of a poly-
peptide antigenically related to chicken erythrocyte a-spectrin
in human and mouse lymphocytes of T- and B-cell lineage, as
judged by immunofluorescence, immunoprecipitation, and im-
munoautoradiography. We have also demonstrated by the same
criteria that a serologically crossreactive form ofchicken eryth-
rocyte f3-spectrin is not present in the same cells. The failure
to detect polypeptides antigenically related to erythrocyte
spectrin in mammalian lymphocytes does not appear to be due
to the inability of the antiserum to crossreact with the corre-
sponding non-avian antigens because we could demonstrate
their presence indirectly in mouse brain. Furthermore, it was
previously shown that these antisera, raised against electro-
phoretically purified a and (3 subunits of chicken erythrocyte
spectrin, do crossreact with mammalian erythrocyte a- and
spectrin, respectively, although the crossreactivity is relatively
weak compared to that with the corresponding antigens in non-
erythroid cells (11, 18).
Although polypeptides antigenically related to erythrocyte
,(3spectrin were not detected in lymphocytes, the polypeptide
that crossreacts with erythrocyte a-spectrin antiserum is spe-
cifically associated, as a doublet, with a 235,000-dalton poly-
peptide. This doublet appears to be similar in polypeptide com-
position to that immunoprecipitated from adult mouse brain,
which has been termed "fodrin" (13). In this respect, it is in-
teresting to note that a preliminary immunofluorescence study
has recently shown that antibodies raised against both compo-
nents of brain fodrin crossreact with a component of the lym-
phocyte plasma membrane, although the crossreacting poly-
peptides were not analyzed (25). Several studies have shown
that fodrin has many biochemical properties in common with
erytirocyte spectrin (15-17). It forms tetramers-composed of
equimolar amounts of the 240,000- and 235,000-dalton poly-
peptides, binds to actin filaments, and is found in association
with the plasma membrane (15-17). However, the two com-
ponents of brain fodrin exhibit peptide maps that are different
from each other as well as from mammalian erythrocyte a- and
(3-spectrin (16, 18). Although it remains to be shown whether
the polypeptides expressed in brain and lymphocytes are the
same gene products, the results of this study indicate that a
polypeptide similar to the lower component of brain fodrin is
also expressed in association with an a-spectrin-related poly-
peptide in lymphocytes.
The fact that the fodrin polypeptide doublet in different cell
types all have a 240,000-dalton polypeptide related to eryth-
rocyte a-spectrin as a common constituent and that the doublet,
at least in nervous tissue, forms a complex biochemically similar
to the erythrocyte spectrin tetramer indicates that the 235,000-
dalton polypeptide component is in fact a member of the spec-
trin family of the polypeptides and as such may be referred to
as y-spectrin. Thus, although several polypeptides in noneryth-
roid cells have biochemical properties similar to those of mam-
malian erythrocyte spectrin, they appear to be different gene
products. This suggests that the genes coding for these poly-
peptides comprise a group of multigene families (see also ref.
17) whose expression is tailored to the functional requirements
of the plasma membrane in different cells (19).
This hypothesis is supported by comparison of the compo-
sition of the polypeptides serologically related to erythrocyte
spectrin that are expressed in lymphocytes and in adult cardiac
muscle cells (18). In the lymphocyte, the cytoskeleton is thought
to play a dynamic role in the mobility of the transmembrane
protein-cell surface receptor complex (see below), whereas in
cardiac muscle cells the cytoskeleton has a more static, struc-
tural role linking the contractile apparatus to the sarcolemma.
Both cell types express a common polypeptide antigenically re-
lated to erythrocyte a-spectrin (this study and ref. 11). How-
ever, whereas adult cardiac muscle cells express polypeptides
antigenically related to erythrocyte (spectrin, lymphocytes ex-
press a 235,000-dalton polypeptide (y-spectrin) that is antigeni-
cally distinct from erythrocyte (3-spectrin. Thus, it appears that
the main difference in the combination of spectrin-related poly-
peptides expressed in different cells is in the polypeptides that
are associated with the a-spectrin-related molecule. This is par-
ticularly interesting because, in the erythrocyte, (3-spectrin as-
sociates with the transmembrane anion transporter through an-
kyrin (for a review, see ref. 10). Whether y-spectrin can also
associate with a polypeptide in lymphocytes that is analogous to
Cell Biology: Nelson et aL
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ankyrin remains to be established.
What is the function of the spectrin complex in lymphocytes?
Our results show that the polypeptide antigenically related to
erythrocyte.a-spectrin is distributed at the cytoplasmic surface
of the lymphocyte plasma.membrane; cell fractionation studies
(unpublished data) also show that this polypeptide (and the
235,000-dalton polypeptide) isrecovered in the membrane frac-
tion. Upon challenge by cell surface-directed ligands such as
ConA or Ig, the redistribution of this polypeptide is coinciden-
tal with that of the.cell-surface receptors: initially in patches and
then a cap. That the redistribution of this polypeptide doublet
during the capping process is the same irrespective of the ligand
used suggests that they may be associated with the plasma mem-
brane-receptor complex in general and not with just one type
of receptor. This is supported by the nonrestricted distribution
of the a-spectrin-related polypeptide in lymphocytes of both B-
and T-cell lineage.and in the null and mastocytoma cell lines as
well. The association of polypeptides related to erythrocyte
spectrin with the lymphocyte plasma membrane and cell-sur-
face receptors is particularly interesting in view of its well-doc-
umented interaction with actin in erythrocytes (for a review, see
ref. 10). Actin filaments are believed to be involved in the re-
distribution of patches of cell-surface receptors into a single cap,
particularly because cytochalasin B is known to inhibit capping
(26) and actin has been shown to be indirectly linked to cell-sur-
face receptors (6, 7). This has led to the hypothesis that there
exists a ubiquitous protein X which binds to the actin microfila-
ment network and associates with the cell-surface receptors via
transmembrane proteins (27-29). The results of this study, to-
gether with the well-documented characteristics of erythrocyte
spectrin and the emerging evidence that erythroid and non-
erythroid spectrin analogues have similar functional properties
(see above) indicate that the role of these spectrin-like poly-
peptides in the lymphocyte is similar to that proposed for pro-
tein X. Klausner. et al. (29) have extended the original hypothesis
to suggest that protein X also binds Ca2 , either directly or in-
directly. In. this respect, it is interesting to note that one of. the
characteristic properties of erythrocyte spectrin and spectrin-
related polypeptides in nonerythroid cells is their ability to in-
teract with calmodulin (14-16, 30). Furthermore, calmodulin
has also been localized at the plasma membrane beneath ligand-
cell surface receptor complexes (31). Because calmodulin has
been implicated in the mediation of various cellular activities
that involve transient fluxes of Ca2" as signals (for a review, see
ref. 32), it may also be involved in changing the Ca2+ concen-
tration locally in the. region of the subcortical actin microfila-.
ment network.
The involvement of polypeptides related to erythrocyte
spectrin in cell-surface receptor capping in lymphocytes. indi-
cates a functional role for these molecules in nonerythroid cells.
Further studies of the interaction of integral proteins of the
plasma membrane with these molecules and the subcortical ac-
tin filament network in lymphocytes will help toward an un-
derstanding of the long-standing problem of how the cytoskele-
ton interacts with the.plasma membrane in nonerythroid cells.
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